224 related articles for article (PubMed ID: 20796263)
21. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS
Retina; 2001; 21(4):339-43. PubMed ID: 11508879
[TBL] [Abstract][Full Text] [Related]
22. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
[TBL] [Abstract][Full Text] [Related]
23. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Kunavisarut P; Bijlsma WR; Pathanapitoon K; Patikulsila D; Choovuthayakorn J; Rothova A
Am J Ophthalmol; 2010 Aug; 150(2):218-22. PubMed ID: 20525529
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India.
Ganekal S; Jhanji V; Dorairaj S; Nagarajappa A
Ocul Immunol Inflamm; 2012 Oct; 20(5):336-41. PubMed ID: 22775065
[TBL] [Abstract][Full Text] [Related]
25. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
Oktavec KC; Nolan K; Brown DM; Dunn JP; Livingston AG; Thorne JE
Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
[TBL] [Abstract][Full Text] [Related]
27. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
28. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
[TBL] [Abstract][Full Text] [Related]
29. The HIV RNA Levels of Plasma and Ocular Fluids in AIDS Patients with Ophthalmic Infections.
Hsu WM; Chiou SH; Chen SS; Shyong MP; Ho CK; Chen SJ; Wu CC; Kung SH; Chi CW
Ophthalmologica; 2004; 218(5):328-32. PubMed ID: 15334014
[TBL] [Abstract][Full Text] [Related]
30. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
31. HIV-associated retinopathy in the HAART era.
Goldberg DE; Smithen LM; Angelilli A; Freeman WR
Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
[TBL] [Abstract][Full Text] [Related]
32. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
Casado JL; Arrizabalaga J; Montes M; Martí-Belda P; Tural C; Pinilla J; Gutierrez C; Portu J; Schuurman R; Aguirrebengoa K
AIDS; 1999 Aug; 13(12):1497-502. PubMed ID: 10465073
[TBL] [Abstract][Full Text] [Related]
34. Current status of HIV infection and ocular disease.
Butler NJ; Thorne JE
Curr Opin Ophthalmol; 2012 Nov; 23(6):517-22. PubMed ID: 23047168
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.
Jabs DA
Am J Ophthalmol; 2011 Feb; 151(2):198-216.e1. PubMed ID: 21168815
[TBL] [Abstract][Full Text] [Related]
36. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
[TBL] [Abstract][Full Text] [Related]
38. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
39. Ocular complications of human immunodeficiency virus infection in eastern china.
Wang Z; Jia R; Ge S; He T; Zhang Y; Yang Y; Wang Y; Shi W; Ji Y; Ye F; Chen P; Lu J; Sun J; Xu X; Zhou Y; Gu P; Luo M; Lu H; Fan X
Am J Ophthalmol; 2012 Feb; 153(2):363-369.e1. PubMed ID: 21982101
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy.
Jabs DA; Holbrook JT; Van Natta ML; Clark R; Jacobson MA; Kempen JH; Murphy RL;
Ophthalmology; 2005 May; 112(5):771-9. PubMed ID: 15878056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]